CVS Health Corp (CVS) is set to report their latest earnings numbers before the opening of trading Wednesday. Let's check out the charts and indicators. WE were bullish in our last review of almost a year ago. On February 16 we wrote "Continue to hold longs from our previous recommendation. Raise stop protection to $71 from below $67. $91 and then $108 are our new price targets."
More from Investing
We'll have to see if the past three months of price action in MSFT represents a key bottom.
To my ears, the Fed chairman did not say anything on Wednesday that merited the incredible stock gains racked up after his remarks.
Positive seasonality could help keep stocks moving higher into the end of the year, but a few economic reports ahead could dampen enthusiasm.
Put plainly, professionals were buying stocks hand over fist on Wednesday, in what was very nearly a state of heated panic.